Current concepts of the pathogenesis and management of asthma.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000336:Aerosols; D000485:Allergens; D000906:Antibodies / Q000032:analysis; D001249:Asthma / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000494:pharmacology; D002395:Catecholamines / Q000008:administration & dosage; D002867:Chromones / Q000008:administration & dosage; D004049:Diethylcarbamazine / Q000008:administration & dosage; D006018:Glycols / Q000008:administration & dosage; D006636:Histamine Release; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007962:Leukocytes / Q000276:immunology; D011433:Propranolol / Q000494:pharmacology; D013147:Spirometry; D013565:Sympatholytics / Q000627:therapeutic use; D013806:Theophylline / Q000008:administration & dosage; D014970:Xanthines / Q000008:administration & dosage; D005719:gamma-Globulins / Q000032:analysis
D000319:Adrenergic beta-Antagonists; D000336:Aerosols; D000485:Allergens; D000906:Antibodies; D001993:Bronchodilator Agents; D002395:Catecholamines; D002867:Chromones; D006018:Glycols; D007136:Immunoglobulins; D013565:Sympatholytics; D014970:Xanthines; D005719:gamma-Globulins; D011433:Propranolol; D013806:Theophylline; D004049:Diethylcarbamazine